Myeloma Trial, Recruiting NCT06559033 Sponsor: University Hospital, Rouen Condition: Myeloma
Back to Myeloma

Myeloma Trial, Recruiting

NCT06559033
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults who have been diagnosed with multiple myeloma (a type of blood cancer involving abnormal plasma cells in the bone marrow, with detectable abnormal protein in the blood or urine, and signs of organ damage related to the disease).
  • Adults who have been diagnosed with MGUS (a condition where a small number of abnormal plasma cells are present in the bone marrow, with low levels of abnormal protein in the blood, and no signs of organ damage).
  • People who are enrolled in a social security scheme.
  • Adults who have read and understood the participant information letter and signed a consent form agreeing to take part.

Who may not be able to join:

  • People who are currently deprived of their liberty through an administrative or court decision, or who are under a legal protection measure such as court protection, sub-guardianship, or guardianship.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 28 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 02 32 88 81 24

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Rouen
Registry
ClinicalTrials.gov
Start date
7 October 2025
Est. completion
2 October 2026

Where this trial is recruiting

🇫🇷 France

Primary endpoints

Frequency of variants in the GBA/PSAP genes in patients with MM or MGUS

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov